Navigation Links
MTI MiniFuge

ProductsMTI MiniFuge
Company MIDSCI
Item MTI MiniFuge
Features Inquire
Description MTI Minifuge has an on/off switch which allows user to stop rotor before opening lid - for improved safety. New hinge, with stainless steel pin is virtually indestructible. Lid release is easy to work yet durable. Spins 6 microcentrifuge tubes at low to medium speed (up to 2000 x g). 6000rpm/2000 x g. 6 inch x 6 inch footprint. Starts and stops in second. Interchangeable rotors. Two rotors included for standard 1.5/2.0ml or PCR strip tubes. Adapters for 0.5 and 0.4ml also included.
Info MIDSCI
Customer Service: (800) 227-9997
Web site: http://www.midsci.com

Related medicine products :

1. Tube-Strip PicoFuge
2. PicoFuge Microcentrifuge (UK only)
3. ProFuge 10K Microcentrifuge
4. Spectrafuge Brush-less 18 Place Microcentrifuge
5. Spectrafuge 24D Digital Microcentrifuge
6. Microcentrifuge Model 5424
7. Microcentrifuge Model 5418
Indications For Usage: ,Used to stabilize/secure orally intubated tracheal tubes without using adhesive tapes.
Indications For Usage: ,Facilitates intubation of tracheal tubes.
Indications For Usage: ,Used to automatically maintain a low intracuff pressure during long-term intubations.
Indications For Usage: ,Microlaryngeal surgery.
Medicine Products:
(Date:8/7/2008)...- Testing men for elevated levels of prostate-spec...rd screening test for prostate cancer -- may be bi...e deceptively low. And this bias may be creating ...ying diagnosis, according to a new study led by in...rham Veterans Affairs (VA) Medical Center. , "W...
(Date:8/7/2008)...oesn,t require fasting, could ID millions who don,...Aug. 7 (HealthDay News) -- A widely used test to m...could help identify millions of people with undete...released by a team of experts. , The hemoglobi...d cells have been exposed to in the previous 120 d...
(Date:8/7/2008)..., Md., Aug. 7 /PRNewswire-USNewswire/ -- Vapotherm...oducts, has received 510(k),clearance from the Foo...(TM), the first high flow humidification system to...cation technology into one device for,the optimal ...her Vapotherm products are currently used in neona...
(Date:8/7/2008)...rves Beneficiary Access to High Quality Nursing Ho... Staffing Efforts, JOPLIN, Mo., Aug. 7 /PRNewswir... protecting the nation,s critical frontline-caregi...r Care (CPSC) today thanked,Senator Pat Roberts fo...in,Congress to stop the Bush Administration from m...
Breaking Medicine News(10 mins):Health News:PSA screening may be biased against obese men, leading to more aggressive cancers 2Health News:Blood Sugar Test May Also Aid Diabetes Detection 2Health News:Vapotherm(R) Precision Flow(TM) Receives FDA 510(k) Clearance 2Health News:Senator Pat Roberts Praised for Leading Successful Effort to Derail $6.2 Million Kansas Medicare Cuts 2
...ry fibrosis (IPF) is a disease whose cause and cur...ment for it till date//. It is a lung disease char...s and slow deterioration of the entire organ (lung...000 Americans suffer from the disease and 31000 ne...
...und that the human form of immune-system protein, ...to make them more infectious//. Cyclophilin A is f...key cells, researchers at University College of Lo..., who infected cells from Old World monkeys with H...
...easingly orienting themselves to video games, high...ternational polling firm//. According to the poll...f the respondents admitted that they enjoyed video...total of 1,046 gamers, taking into consideration t...
... the Taiwan Laughter Club gathered in a central Ta...brate the World Laughter Day//. Led by founder Che...hanted 'Ho-Ho-Ho, Ha-Ha-Ha' several times before b...ith names like lion laugh, milkshake laugh and inn...
Other Medicine News:Health News:Lesser Know Facts about Idiopathic Pulmonary Fibrosis (IPF) 2Health News:Taiwanese Had A Hearty Laugh On World Laughter Day 2
(Date:8/6/2008)... Milestone achievement triggers $15 million payme...axoSmithKline, CAMBRIDGE, Mass., Aug. 6 /PRNewswi...ngaged in the discovery and development of novel,t...nced the initiation of a,pivotal Phase 3 clinical ...e new onset type 1 diabetes. As a result of the in...
(Date:8/5/2008)... National trial aims to help heart failure patien...lot risk and less blood damage than,earlier heart ...ewswire/ -- Anthony Shannon,made history on July 3...nited States to receive a new type of experimental...DuraHeart, it was implanted in his chest, and,conn...
(Date:8/5/2008)... CAMBRIDGE, Mass., Aug. 5 /- Tolerx,...discovery and development of novel,therapies for t...d today,that Genentech, a collaborator, has moved ... monoclonal antibody, into a phase 1 clinical tria...trial is evaluating the,safety and tolerability of...
(Date:8/5/2008)...irst Patients Treated Using Next Generation CyberK...CyberKnife Center, SUNNYVALE, Calif., Aug. 5 /PRN...: ARAY ), a global leader in the field of radiosu...e treated using the next,generation CyberKnife(R) ...alled at the Oklahoma CyberKnife, LLC in Tulsa, OK...
Breaking Medicine Technology:Tolerx Initiates Dosing of Otelixizumab, a Novel Type 1 Diabetes Agent, in DEFEND, a Phase 3 Clinical Trial 2Tolerx Initiates Dosing of Otelixizumab, a Novel Type 1 Diabetes Agent, in DEFEND, a Phase 3 Clinical Trial 3Tolerx Initiates Dosing of Otelixizumab, a Novel Type 1 Diabetes Agent, in DEFEND, a Phase 3 Clinical Trial 4First U.S. Patient to Receive New Heart-Assist Device Doing Well After Surgery at University of Michigan 2First U.S. Patient to Receive New Heart-Assist Device Doing Well After Surgery at University of Michigan 3First U.S. Patient to Receive New Heart-Assist Device Doing Well After Surgery at University of Michigan 4Tolerx Announces Achievement of Milestones upon anti-CD4 Antibody Program Advancement and Initiation of Phase 1 Clinical Trial 2Tolerx Announces Achievement of Milestones upon anti-CD4 Antibody Program Advancement and Initiation of Phase 1 Clinical Trial 3New CyberKnife Technologies Demonstrate Dramatic Reduction in Treatment Times 2New CyberKnife Technologies Demonstrate Dramatic Reduction in Treatment Times 3New CyberKnife Technologies Demonstrate Dramatic Reduction in Treatment Times 4Boston Scientific To Webcast Conference Call Discussing Second Quarter Financial Results 6259 1Boston Scientific To Webcast Conference Call Discussing Second Quarter Financial Results 6259 2American Telugu Association 26apos 3Bs Convention Attracts Over 10 000 People in the U S 6257 1American Telugu Association 26apos 3Bs Convention Attracts Over 10 000 People in the U S 6257 2American Telugu Association 26apos 3Bs Convention Attracts Over 10 000 People in the U S 6257 3American Telugu Association 26apos 3Bs Convention Attracts Over 10 000 People in the U S 6257 4Impact Systems Announces Completion of Successful Enterprise Content Migrations to Documentum 6 6255 1Impact Systems Announces Completion of Successful Enterprise Content Migrations to Documentum 6 6255 2Impact Systems Announces Completion of Successful Enterprise Content Migrations to Documentum 6 6255 3Why do people vote 3F Genetic variation in political participation 3781 1Why do people vote 3F Genetic variation in political participation 3781 2
...atients and physicians should find these data reas...irstCall/ --,GlaxoSmithKline said today that findi...one Evaluated for Cardiac Outcomes and,Regulation ...rial,designed specifically to determine cardiovasc...e 2 diabetes, adds further evidence to,the overall...
...W YORK--(BUSINESS WIRE)--Jun 5, 2007 - ERBITUX (ce...ody targeting the epidermal,growth factor receptor...stems Incorporated, was the focus of nine oral and... 43rd Annual Meeting,of the American Society of Cl...presentations showcased the extensive,clinical dev...
Other Medicine Technology:Interim Data From RECORD Study Show No Significant Difference,Between Avandia and Standard Therapy in Risk of Cardiovascular,Hospitalization or Death 2Interim Data From RECORD Study Show No Significant Difference,Between Avandia and Standard Therapy in Risk of Cardiovascular,Hospitalization or Death 3Interim Data From RECORD Study Show No Significant Difference,Between Avandia and Standard Therapy in Risk of Cardiovascular,Hospitalization or Death 4Interim Data From RECORD Study Show No Significant Difference,Between Avandia and Standard Therapy in Risk of Cardiovascular,Hospitalization or Death 5Extensive Clinical Data on Erbitux Presented at the 2007 ASCO,Annual Meeting 2Extensive Clinical Data on Erbitux Presented at the 2007 ASCO,Annual Meeting 3Extensive Clinical Data on Erbitux Presented at the 2007 ASCO,Annual Meeting 4Extensive Clinical Data on Erbitux Presented at the 2007 ASCO,Annual Meeting 5Extensive Clinical Data on Erbitux Presented at the 2007 ASCO,Annual Meeting 6Extensive Clinical Data on Erbitux Presented at the 2007 ASCO,Annual Meeting 7Extensive Clinical Data on Erbitux Presented at the 2007 ASCO,Annual Meeting 8Extensive Clinical Data on Erbitux Presented at the 2007 ASCO,Annual Meeting 9Extensive Clinical Data on Erbitux Presented at the 2007 ASCO,Annual Meeting 10